Drugs / Rubidium
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03048097 | Feb 2017 → Jul 2018 | sarcoidosis | Yale University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rubidium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03048097 ↗ |
| Modality | Diagnostic / imaging agent | “used in PET scans” NCT03048097 ↗ |